FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control When compounded semaglutide and tirzepatide fail sterility and potency testing, and get distributed anyway, the implications extend far beyond one pharmacy
Last updated on Jan 05, 2026
2021;13(6):e16073
During your consultation, your doctor will review your medical history, focusing on any chronic conditions such as diabetes, heart disease, or kidney problems that might impact the safety and effectiveness of the treatment
What should I do if my blood sugar drops too low whilst taking retatrutide
Zalewska A, Maciejczyk M, Szulimowska J, Imierska M, Blachnio-Zabielska A